| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/03/2006 | EP1056459B1 Treatment of hiv infections |
| 05/03/2006 | EP1051434B1 G protein-coupled receptor |
| 05/03/2006 | EP1015481B1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection |
| 05/03/2006 | EP0625047B1 Platelet transfusion |
| 05/03/2006 | CN1768078A Antibodies directed against hepatitis c virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions |
| 05/03/2006 | CN1768076A Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof. |
| 05/03/2006 | CN1767852A Antibody vaccine conjugates and uses therefor |
| 05/03/2006 | CN1767848A Survivin-derived peptides and use thereof |
| 05/03/2006 | CN1766108A T1R taste receptors and genes encoding same |
| 05/03/2006 | CN1765928A Reconstituted human anti-hm1.24 antibody |
| 05/03/2006 | CN1765927A Axin antibody C8 preparation method |
| 05/03/2006 | CN1254541C Novel compound |
| 05/03/2006 | CN1254487C Reformed monoclonal antibody for resisting immunoglobulin homoeotype |
| 05/03/2006 | CN1254485C Human lung cancer antigen and its antibody |
| 05/03/2006 | CN1254275C Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 05/03/2006 | CN1254272C Activation and inhibition of immune system |
| 05/02/2006 | US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering |
| 05/02/2006 | US7038021 Anti-dioxins monoclonal antibody suitable for assaying dioxins in environment and hybridoma producing the same |
| 05/02/2006 | US7038020 Diagnosis of RH factor; using polypeptides to form antibodies |
| 05/02/2006 | US7038019 Polypeptides; binding to labeled, human monoclonal antibodies |
| 05/02/2006 | US7038018 Antibodies and ligands for “Bonzo” chemokine receptor |
| 05/02/2006 | US7038017 Antibody purification |
| 05/02/2006 | US7038014 Seafood protein; measuring water absorption of fish bladder |
| 05/02/2006 | US7038013 Nucleotide sequences coding polypeptide for use in treatment of immune respone defects |
| 05/02/2006 | US7037896 HIV inhibiting peptide (VIRIP) and amidated, acetylated, sulfated, polyethylene glycol modified, phosphorylated and/or glycosylated derivatives |
| 05/02/2006 | US7037894 Balancing physical properties of a polypeptide; obtain sample, crosslink tyrosine residues, monitor physical properties of polypeptide |
| 05/02/2006 | US7037891 Polypeptides; antidiabetic agents, cardiovascular disorders; hypotensive agent, antilipemic agents |
| 05/02/2006 | US7037719 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 05/02/2006 | US7037709 Comprises nucleotide sequences coding microsomal enzymes for detoxification of xenobiotic compounds in liver; drug screening; gene therapy |
| 05/02/2006 | US7037702 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents |
| 05/02/2006 | US7037701 Genetic engineering; detection moderators of kinase peptidespeptides |
| 05/02/2006 | US7037699 Human extracellular signal regulated kinases |
| 05/02/2006 | US7037675 Genetic engineering; generation antibodies; culture product |
| 05/02/2006 | US7037669 Assays for amphetamine and methamphetamine using stereospecific reagents |
| 05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |
| 05/02/2006 | US7037664 Apoptosis marker antibodies and methods of use |
| 05/02/2006 | US7037647 Prostate-specific membrane antigen and uses thereof |
| 05/02/2006 | US7037510 Hybrids of M. tuberculosis antigens |
| 05/02/2006 | US7037503 Compounds and methods for the treatment and prevention of bacterial infection |
| 05/02/2006 | US7037501 Administering to the egg- laying vertebrate or to an egg of the vertebrate the vaccine of immunoconjugate of myostatin polypeptide linked to a carrier to increase muscle weight |
| 05/02/2006 | US7037498 Antibodies to insulin-like growth factor I receptor |
| 05/02/2006 | US7037496 Chimeric immunoglobulin for CD4 receptors |
| 05/02/2006 | US7037495 Antimicrobial compositions |
| 05/02/2006 | CA2149529C Peptides and anti-sense peptides with broad neoplastic specificity |
| 04/27/2006 | WO2006045049A1 Angiopoietin-2 specific binding agents |
| 04/27/2006 | WO2006044410A2 A32 monoclonal antibody fusion proteins for use as hiv inhibitors and vaccines |
| 04/27/2006 | WO2006044336A1 Methods for increasing the diversity of monoclonal antibodies produced against an antigen |
| 04/27/2006 | WO2006044333A2 Methods and materials for the inhibition of transplant rejection |
| 04/27/2006 | WO2006043896A1 Chromatography ligand |
| 04/27/2006 | WO2006043895A1 A method of antibody purification |
| 04/27/2006 | WO2006043891A1 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases |
| 04/27/2006 | WO2006043271A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 04/27/2006 | WO2006042745A2 Chemically modified peptide analogs |
| 04/27/2006 | WO2006013474A8 Ppgalnac-t6 mrna or peptide as a new marker for detection cancer cells |
| 04/27/2006 | WO2006005940A3 Monoclonal anti-glut2 antibody |
| 04/27/2006 | WO2006003407A3 Chimeric and humanised monoclonal antibodies against inteleukin- 13 |
| 04/27/2006 | WO2006003388A3 Compositions and methods for treating inflammatory disorders |
| 04/27/2006 | WO2006002057A3 Treatment of acne |
| 04/27/2006 | WO2006000787A3 Antibodies against bacterial antigens and their use in the generation of immune responses against apoptotic cells |
| 04/27/2006 | WO2005118627A3 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 04/27/2006 | WO2005117972A3 Preventing autoimmune disease by using an anti-cd20 antibody |
| 04/27/2006 | WO2005117848A9 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 04/27/2006 | WO2005115459A3 Anti-viral activity of an anti-thymidine kinase monoclonal antibody |
| 04/27/2006 | WO2005113586A3 Disease-associated proteins |
| 04/27/2006 | WO2005108430A3 Monoclonal antibody sc104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent |
| 04/27/2006 | WO2005108427A3 Method for producing soluble mhc proteins |
| 04/27/2006 | WO2005105143A3 Vaccines and antibodies against ltk for therapy of cancers. |
| 04/27/2006 | WO2005099755A3 Methods of treating autoimmune and inflammatory diseases |
| 04/27/2006 | WO2005095457A3 Immunoglobulins |
| 04/27/2006 | WO2005094348A3 Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer |
| 04/27/2006 | WO2005081980A3 Methods and compositions relating to chitinases and chitinase-like molecules and modulation of osteoclasts |
| 04/27/2006 | WO2005077462A3 Cd70 inhibition for the treatment and prevention of inflammatory bowel disease |
| 04/27/2006 | WO2005072241A3 Inhibition of bright function as a treatment for excessive immunoglobulin production |
| 04/27/2006 | WO2005027847A3 Antibodies for use against sars |
| 04/27/2006 | WO2005025603A3 Methods of using wisp antagonists |
| 04/27/2006 | WO2005018424A3 Antibodies specific for fibrillar amyloid and a procedure to detect fibrillar amyloid deposits |
| 04/27/2006 | WO2004035603A3 Erythropoietin receptor binding antibodies |
| 04/27/2006 | WO2004032828A3 Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders |
| 04/27/2006 | WO2004001064A3 Serum protein-associated target-specific ligands and identification method therefor |
| 04/27/2006 | WO2003033665A3 Secreted protein, ztnf9 |
| 04/27/2006 | US20060089493 Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas |
| 04/27/2006 | US20060089491 FAS Ligand Derived Polypeptides |
| 04/27/2006 | US20060089490 Survival motor neuron (SMN) gene: a Gene for spinal muscular atrophy |
| 04/27/2006 | US20060089303 Cancer-testis antigens |
| 04/27/2006 | US20060089302 Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases |
| 04/27/2006 | US20060089297 Sperm specific lysozyme-like proteins |
| 04/27/2006 | US20060088933 Immunogenic label for detection of low concentrations of viral therapeutics/antibodies in blood; diagnosing/detecion/monitoring viral drug resistance; immunoassay |
| 04/27/2006 | US20060088917 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/27/2006 | US20060088916 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/27/2006 | US20060088915 A G protein-coupled receptor protein for the treatment of digestive diseases |
| 04/27/2006 | US20060088913 Mutation associated with epilepsy |
| 04/27/2006 | US20060088893 Prostate cancer therapeutics and diagnostics based on conformers of prostatic cid phosphatase |
| 04/27/2006 | US20060088890 Identification and isolation of somatic stem cells and uses thereof |
| 04/27/2006 | US20060088883 Recombinant catalytic polypeptides and their uses |
| 04/27/2006 | US20060088882 Methods for the treatment or prevention of obesity |
| 04/27/2006 | US20060088832 Tap-70, a novel marker for epithelial tumors |
| 04/27/2006 | US20060088827 Diagnostic and therapeutic use of a voltage-gated ion channel scn2a for neurodegenerative diseases |
| 04/27/2006 | US20060088824 Used in assays to identify PAP-1/WIP-1 interaction inhibitors; West Nile virus (WNV) |
| 04/27/2006 | US20060088820 Detecting superantigen activity in a biological sample |
| 04/27/2006 | US20060088548 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |